Breaking News
19 minutes ago
Simantini Singh Deo
Achieve Life Sciences appoints Ronald Dadino as SVP of CMC/Supply Chain and Gloria Cosgrove as SVP of Quality as cytisinicline nears U.S. launch.
Simantini Singh Deo
Altimmune starts its global Phase 3 PERFORMA trial evaluating pemvidutide for MASH liver disease, following promising Phase 2b clinical results.
Simantini Singh Deo
Novo Nordisk's ziltivekimab misses its Phase III cardiovascular endpoint, intensifying pressure to diversify beyond obesity.
Simantini Singh Deo

AstraZeneca and Bristol Myers Squibb reportedly held preliminary merger talks for a combined company worth almost $400 billion.
Simantini Singh Deo
